XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Share-Based Payments: (Tables)
 6 Months Ended
Jun. 30, 2023
Equity:  
The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023:

The following table sets forth information with respect to nonvested options for the six months ended June 30, 2023:

 

   Number of Shares   Weighted Average Grant-Date Fair Value 
Nonvested options – beginning of period   168,730   $16.31 
Nonvested options granted   —    — 
Nonvested options vested or forfeited   (23,560)  $13.59 
Nonvested options – end of period   145,170   $16.75 
The following table summarizes stock option information as of June 30, 2023:

The following table summarizes stock option information as of June 30, 2023:

 

   Shares   Weighted Average Exercise Price 
         
Outstanding at January 1, 2023   441,580   $67.30 
Options forfeited   (15,960)   70.48 
Options exercised   (93,430)   55.57 
           
Outstanding at June 30, 2023   332,190   $70.44 
           
Options exercisable   187,020   $61.53 
Options available for future grants   574,935      
Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows:

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the six months ended June 30, 2023 and 2022 were as follows:

 

(In thousands)  June 30,
2023		   June 30, 
2022		 
         
Cash proceeds from stock options exercised  $5,192   $810 
Tax benefits   840    75 
Intrinsic value of stock options exercised   5,773    698